GABC vs GILD · P/E 16, rev $249.9M vs P/E 18, rev $7.80B
German American Bancorp Inc (GABC) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
German American Bancorp Inc (GABC) is a banks - regional company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported GABC revenue for 2026-06-30 was $249.9M. Net income was $71.3M. GABC currently screens at market cap $1.53B and trailing P/E 16.4.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
GABC currently screens at market cap $1.53B and trailing P/E 16.4. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the GABC and GILD stock pages for the full models.
Not investment advice.